Publicaciones en colaboración con investigadores/as de Fundación Hospital Alcorcón (8)

2007

  1. The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats

    Pediatric Research, Vol. 62, Núm. 3, pp. 255-260

  2. The seek of neuroprotection: Introducing cannabinoids

    Recent Patents on CNS Drug Discovery, Vol. 2, Núm. 2, pp. 131-139

2006

  1. Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats

    Pediatric Research, Vol. 60, Núm. 2, pp. 169-173

  2. Nitric oxide synthase as a target for the prevention of hypoxic-ischemic newborn brain damage

    Current Enzyme Inhibition, Vol. 2, Núm. 3, pp. 219-229

2005

  1. Immature rat brain slices exposed to oxygen-glucose deprivation as an in vitro model of neonatal hypoxic-ischemic encephalopathy

    Journal of Neuroscience Methods, Vol. 145, Núm. 1-2, pp. 205-212

  2. Neuroprotective effect of L-arginine in a newborn rat model of acute severe asphyxia

    Biology of the Neonate, Vol. 88, Núm. 4, pp. 291-298

  3. The cannabinoid system and its importance in the perinatal period

    Anales de Pediatria, Vol. 63, Núm. 5, pp. 433-440

2004

  1. Evolución de la hiperglicinemia no cetósica neonatal en tratamiento

    Revista de Neurologia, Vol. 39, Núm. 8, pp. 727-730